SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 25.48 |
| Enterprise Value ($M) | 17.03 |
| Book Value ($M) | 8.50 |
| Book Value / Share | 0.90 |
| Price / Book | 3.00 |
| NCAV ($M) | 8.26 |
| NCAV / Share | 0.88 |
| Price / NCAV | 3.08 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -2.81 |
| Return on Assets (ROA) | -1.50 |
| Return on Equity (ROE) | -2.67 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.17 |
| Current Ratio | 4.17 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 10.87 |
| Assets | 11.11 |
| Liabilities | 2.61 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Armistice Capital, Llc | 9.99 | -69.59 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 365,379 | 945,995 | 38.62 | |
| 230,980 | 589,518 | 39.18 | |
| 410,408 | 1,189,226 | 34.51 | |
| 444,581 | 1,377,014 | 32.29 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| GLTO – Galecto, Inc. | GNLX – Genelux Corporation |
| GNPX – Genprex, Inc. | GRCE – Grace Therapeutics, Inc. |
| GTBP – GT Biopharma, Inc. |
Financial data and stock pages provided by
Fintel.io